Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merrick I Ross

Showing results (81-90 of 286) with videos related to

Pageof 29
Sort By:
Annals of Surgical Oncology|July 4, 2002
Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patientsJeffrey E Lee, Joseph Abdalla, Geoffrey A Porter, et al.
Annals of Surgical Oncology|March 13, 2002
Frequency of nonsentinel lymph node metastasis in melanomaKelly M McMasters, Sandra L Wong, Michael J Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Cost effectiveness of adjuvant interferon in node-positive melanomaJanice N Cormier, Yan Xing, Meichun Ding, et al.
Annals of Surgical Oncology|December 4, 2004
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanomaMatthew T Ballo, Gunar K Zagars, Jeffrey E Gershenwald, et al.
Journal of Surgical Oncology|September 28, 2018
A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph nodeNeal Bhutiani, Michael E Egger, Arnold J Stromberg, et al.
Cancer|July 29, 2009
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanomaGeorgia M Beasley, Nicole McMahon, Gretchen Sanders, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weightsRobert L Askew, Richard J Swartz, Yan Xing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2002
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanomaZhigang Duan, Hongbing Shen, Jeffrey E Lee, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 2, 2002
Interval sentinel lymph nodes in melanomaKelly M McMasters, Celia Chao, Sandra L Wong, et al.
Journal of Surgical Oncology|March 27, 2024
Vascular stenting of a malignant arterial blowout as a bridge to effective systemic and regional therapyTaylor P Williams, Mitchell W Cox, Bagi Jana, et al.
Pageof 29

Showing results (81-90 of 286) with videos related to

Sort By:
Pageof 29
Annals of Surgical Oncology|July 4, 2002
Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patientsJeffrey E Lee, Joseph Abdalla, Geoffrey A Porter, et al.
Annals of Surgical Oncology|March 13, 2002
Frequency of nonsentinel lymph node metastasis in melanomaKelly M McMasters, Sandra L Wong, Michael J Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2007
Cost effectiveness of adjuvant interferon in node-positive melanomaJanice N Cormier, Yan Xing, Meichun Ding, et al.
Annals of Surgical Oncology|December 4, 2004
A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanomaMatthew T Ballo, Gunar K Zagars, Jeffrey E Gershenwald, et al.
Journal of Surgical Oncology|September 28, 2018
A model for predicting low probability of nonsentinel lymph node positivity in melanoma patients with a single positive sentinel lymph nodeNeal Bhutiani, Michael E Egger, Arnold J Stromberg, et al.
Cancer|July 29, 2009
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanomaGeorgia M Beasley, Nicole McMahon, Gretchen Sanders, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weightsRobert L Askew, Richard J Swartz, Yan Xing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 12, 2002
DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanomaZhigang Duan, Hongbing Shen, Jeffrey E Lee, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 2, 2002
Interval sentinel lymph nodes in melanomaKelly M McMasters, Celia Chao, Sandra L Wong, et al.
Journal of Surgical Oncology|March 27, 2024
Vascular stenting of a malignant arterial blowout as a bridge to effective systemic and regional therapyTaylor P Williams, Mitchell W Cox, Bagi Jana, et al.
Pageof 29